# US 2014/0155389 A1 · Bicyclic inhibitors of alk

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0155389 A1
- Document ID: US20140155389A1
- Status: Published application
- Kind: A1
- Application number: 13/979,389
- Filed: 2012-01-20
- Published: 2014-06-05
- Earliest claimed: 2011-01-21
- Assignees: AbbVie Inc.
- Inventors: Anil Vasudevan; Thomas Dale Penning; Huanming Chen; Bo Liang; Shaohui Wang; Zhongqiang Zhao; Dikun Chai; Leifu Yang; Yingxiang Gao; Marina Pliushchev
- Web page: https://patentgrep.com/patent/US20140155389A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 35/00: Antineoplastic agents
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R1, X, Y, Z, A, B, G1, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.

## Claims

### Claim 1

A compound of formula (I):
X is CH or N;
Y is CH or N;
wherein at least one of X and Y is N;
A is phenyl, naphthyl, indenyl, C3-8 cycloalkyl, 4-7 membered heterocycloalkyl, 5-7 membered heterocycloalkenyl, or 5-7 membered heteroaryl;
B is
(a) phenyl, naphthyl, tetrahydronaphthyl, indenyl, or indanyl, wherein the phenyl, naphthyl, tetrahydronaphthyl, indenyl, or indanyl is optionally substituted with one, two, three, or four R2 and is substituted with R3; or
(b) 5-16 membered monocyclic, bicyclic, or tricyclic heterocyclyl, wherein the heterocyclyl is optionally substituted with one, two, three, four, or five R4;
Z is a bond, C1-6 alkylene, C2-6 alkenylene, —O— or —NR5—;
R1, at each occurrence, is independently selected from the group consisting of halo, CN, NO2, C1-6-alkyl, C1-6-haloalkyl, aryl, C3-8 cycloalkyl, heteroaryl, heterocycloalkyl, OR6, SR6, C(O)R6, C(O)NR7R8, C(O)OR6, OC(O)R6, OC(O)NR7R8, NR7R8, NR7C(O)R6, S(O)R6, S(O)NR7R8, S(O)2R6, NR7S(O)2R6, and S(O)2NR7R8; wherein the C3-8 cycloalkyl, aryl, heterocycloalkyl, and heteroaryl are optionally substituted with 1, 2, or 3 substituents independently selected from halo, C1-6 alkyl, C1-6 haloalkyl, CN, NO2, ORa, SRa, C(O)Ra, C(O)NRbRc, C(O)ORa, OC(O)Ra, OC(O)NRbRc, NRbRc, NRbC(O)Ra, S(O)Ra, S(O)NRbRc, S(O)2Ra, NRbS(O)2Ra, and S(O)2NRbRc;
R2, at each occurrence, is independently selected from the group consisting of halo, CN, OH, C1-6 alkyl, C1-6-haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6-thioalkoxy, amino, C1-6 alkylamino, and C1-6 dialkylamino;
R3 is selected from the group consisting of aryl, C3-8 cycloalkyl, heteroaryl, heterocycloalkyl, aryl-C1-6-alkyl-, C3-8 cycloalkyl-C1-6-alkyl-, heteroaryl-C1-6-alkyl-, heterocycloalkyl-C1-6-alkyl-, OR9, C(O)R9, —C1-6-alkyl-C(O)R9, C(O)NR10R11, C(O)OR9, OC(O)R9, OC(O)NR10R11, NR10R11, NR10C(O)R9, S(O)R9, S(O)NR10R11, S(O)2R9, NR10S(O)2R9, and S(O)2NR10R11, wherein the C3-8 cycloalkyl, aryl, heterocycloalkyl, and heteroaryl, alone or part of another moiety, are optionally substituted with one, two, or three R12;
R4 is CN, NO2, halo, C1-6-alkyl, C1-6-haloalkyl, ORj, SRj, C(O)Rd, C(O)NReRf, C(O)ORd, NReRf, NReC(O)Rd, S(O)2Rd, NReS(O)2Rd, or S(O)2NReRf;
R5 is H or C1-6-alkyl;
R6, R7, and R8, at each occurrence, are independently selected from H, C1-6 alkyl, C1-6 haloalkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl, wherein the aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl moiety are optionally substituted with 1, 2, or 3 substituents independently selected from halo, CN, OH, C1-6 alkyl, C1-6-haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, C1-6 dialkylamino, C(O)OH, C(O)C1-6 alkyl, C(O)NH2, C(O)NH(C1-6 alkyl), or C(O)N(C1-6 alkyl)2;
R9, R10, and R11, at each occurrence, are independently selected from H, C1-6 alkyl, C1-6 haloalkyl, heteroaryl-C1-6-alkyl-, heterocycloalkyl-C1-6-alkyl-, R13R14N—C1-6-alkyl-, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl, wherein the aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl, alone or as part of another moiety, are optionally substituted with 1, 2, or 3 substituents independently selected from halo, CN, OH, C1-6 alkyl, C1-6-haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkylamino, C1-6 dialkylamino, C(O)OH, C(O)C1-6 alkyl, C(O)NH2, C(O)NH(C1-6 alkyl), or C(O)N(C1-6 alkyl)2;
R12, at each occurrence, is independently selected from the group consisting of halo, C1-6 alkyl, C1-6 haloalkyl, amino-C1-6-alkyl-, C1-6 alkylamino-C1-6 alkyl-, C1-6 dialkylamino-C1-6 alkyl-, hydroxy-C1-6-alkyl-, C1-6 alkyl-C1-6 alkoxy, aryl, C3-8 cycloalkyl, heteroaryl, heterocycloalkyl, aryl-(C1-6 alkyl)-, C3-8 cycloalkyl-(C1-6 alkyl)-, heteroaryl-(C1-6 alkyl)-, heterocycloalkyl-(C1-6 alkyl)-, CN, NO2, ORg, SRg, C(O)Rg, C(O)NRhRi, C(O)ORg, OC(O)Rg, OC(O)NRhRi, NRhRi, NRhC(O)Rg, S(O)Rg, S(O)NRhRi, S(O)2Rg, NRhS(O)2Rg, and S(O)2NRhRi, wherein the aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl, alone or as part of another moiety, are optionally substituted with one, two or three substituents independently selected from halo and C1-6 alkyl;
R13 and R14, at each occurrence, are independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Ra, at each occurrence, is independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Rb and Rc, at each occurrence, are independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Rd, at each occurrence, is independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Re and Rf, at each occurrence, are independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Rg, at each occurrence, is independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2;
Rh and Ri, at each occurrence, are independently selected from the group consisting of H, C1-6 alkyl, aryl, C3-8 cycloalkyl, heteroaryl, and heterocycloalkyl; wherein the C1-6-alkyl is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxy, C1-6-alkoxy, —NH2, —NHC1-6-alkyl, and —N(C1-6-alkyl)2, and wherein the aryl, C3-8 cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more substituents selected from the group consisting of halo, C1-6-alkyl, C1-6-haloalkyl, C1-6-hydroxyalkyl, hydroxy, oxo, C1-6-alkoxy, C1-6-haloalkoxy, —NH2, —NH(C1-6-alkyl), and N(C1-6-alkyl)2; and
n is 0, 1, 2, or 3;
or a pharmaceutically acceptable salt or solvate thereof.

### Claim 2 (depends on 1)

The compound of claim 1 of formula (I) wherein G1 is
X is N; and
Y is CH.

### Claim 3 (depends on 1)

The compound of claim 1 of formula (I) wherein G1 is
X is CH; and
Y is N.

### Claim 4 (depends on 1)

The compound of claim 1 of formula (I) wherein G1 is
X is N; and
Y is CH.

### Claim 5 (depends on 1)

The compound of claim 1 of formula (I) wherein Z is bond.

### Claim 6 (depends on 1)

The compound of claim 1 of formula (I) wherein Z is C1-6 alkylene.

### Claim 7 (depends on 1)

The compound of claim 1 of formula (I) wherein Z is —O—.

### Claim 8 (depends on 1)

The compound of claim 1 of formula (I) wherein Z is —NR5(CH2)p—.

### Claim 9 (depends on 1)

The compound of claim 1 of formula (I) wherein A is phenyl, wherein R1 is selected from the group consisting of halo, CN, NO2, C1-6-alkyl, C1-6-haloalkyl, OR6, SR6, C(O)R6, C(O)OR6, NR7R8, and S(O)R6.

### Claim 10 (depends on 9)

The compound of claim 9 of formula (I) wherein the phenyl is substituted with two R1, and R1 is halo.

### Claim 11 (depends on 1)

The compound of claim 1 of formula (I) wherein B is phenyl.

### Claim 12 (depends on 13)

The compound of claim 13 of formula (I) wherein R3 is heterocycloalkyl.

### Claim 13 (depends on 1)

The compound of claim 1 of formula (I) wherein
B is
R2 is halo, C1-6-alkyl, C1-6 haloalkyl, or OR6; and p is 0, 1, or 2.

### Claim 14 (depends on 1)

The compound of claim 1 of formula (I), or a pharmaceutically acceptable salt or solvate thereof, selected from the group consisting of
7-(2,6-dichlorobenzyl)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-2,3-dihydropyrido[4,3-d]pyrimidin-4(1H)-one;
7-(2,6-dichlorobenzyl)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
8-(2,6-dichlorobenzyl)-6-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-1,2,3,4-tetrahydro-5H-pyrido[2,3-e][1,4]diazepin-5-one;
8-(2,6-dichlorobenzyl)-6-{[4-(piperazin-1-yl)phenyl]amino}-1,2,3,4-tetrahydro-5H-pyrido[2,3-e][1,4]diazepin-5-one;
7-(2,6-dichlorobenzyl)-5-{[4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
8-(2,6-dichlorobenzyl)-6-{[4-(piperazin-1-yl)phenyl]amino}-1,2,3,4-tetrahydro-5H-pyrido[4,3-e][1,4]diazepin-5-one;
7-(2,6-dichlorobenzyl)-5-{[3-methyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[4-(4-cyclohexylpiperazin-1-yl)-2-methoxyphenyl]amino}-7-(2,6-dichlorobenzyl)pyrido[3,4-d]pyridazin-4(3H)-one;
[4-(4-{[7-(2,6-dichlorobenzyl)-4-hydroxypyrido[3,4-d]pyridazin-5-yl]amino}-3-methoxyphenyl)piperazin-1-yl](phenyl)methanone;
7-[(2,6-dichlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[4-(propan-2-ylsulfonyl)piperazin-1-yl]phenyl}amino)pyrido[3,4-d]pyridazin-4-ol;
1-[4-(4-{[7-(2,6-dichlorobenzyl)-4-hydroxypyrido[3,4-d]pyridazin-5-yl]amino}-3-methoxyphenyl)piperazin-1-yl]-2-(dimethylamino)ethanone;
5-{[3-chloro-4-(piperazin-1-yl)phenyl]amino}-7-(2,6-dichlorobenzyl)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]phenyl}amino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[4-(3-methylbutyl)piperazin-1-yl]phenyl}amino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[2-(pyrrolidin-1-yl)ethyl]phenyl}amino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[2-oxo-2-(pyrrolidin-1-yl)ethyl]phenyl}amino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-({2-methoxy-4-[4-(3-methylbutanoyl)piperazin-1-yl]phenyl}amino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2,5-difluoro-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2,6-dimethyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-{[2-(propan-2-ylsulfonyl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-{[(4R)-4-(propan-2-yl)-4,5-dihydro-1,3-oxazol-2-yl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(2-chlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(5-chloro-2-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2-fluoro-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2-chloro-5-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,5-dichlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2-chloro-6-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(3,5-dichlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,6-difluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(3,5-dichloropyridin-4-yl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,4-dichlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(2,6-dichloro-4-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(2,3-difluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(furan-2-ylmethyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(piperidin-1-yl)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(benzylamino)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-phenylpyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2,6-difluoro-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(pyridin-2-ylamino)pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(pyridin-3-ylamino)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(cyclohexylamino)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-{[2-(pyridin-2-yl)ethyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(2-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,6-dimethylphenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(3-chloropyridin-2-yl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,3-dichlorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-[(2,4,6-trifluorophenyl)amino]pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-[(2,3,4-trifluorophenyl)amino]pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(3-chloro-2-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(tetrahydro-2H-pyran-4-ylamino)pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(1,3-thiazol-2-ylamino)pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-chloro-4-(piperazin-1-yl)phenyl]amino}-7-(2,6-dichlorobenzyl)pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-[(1-methylpiperidin-4-yl)amino]pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[3-fluoro-2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(3-chloropyridin-4-yl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-bromo-4-(piperazin-1-yl)phenyl]amino}-7-(2,6-dichlorobenzyl)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2-chlorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[4-(piperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(2,3-dichloro-6-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)iphenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[4-(hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-2-methoxyphenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(2,3-dichloro-4-fluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
2-[(2,6-dichlorophenyl)amino]-4-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
7-(2,6-dichlorobenzyl)-5-{[2,3-dimethyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
2-(2,6-dichlorobenzyl)-4-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
7-[(2-chloro-4,6-difluorophenyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(2,6-dichlorobenzyl)-5-{[2-methoxy-5-methyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichlorobenzyl)-5-{[2-fluoro-5-methyl-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
6-(2,6-dichlorobenzyl)-8-[(6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]phthalazin-1(2H)-one;
7-(2,6-difluorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2-fluorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-[(2,3,4-trichlorophenyl)amino]pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,3-difluorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(2,3-dichlorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,6-dichloro-4-fluorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(3-chloropyridin-4-yl)oxy]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2,3-dimethylphenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(3-fluoropyridin-4-yl)oxy]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-7-(2,3,4-trichlorophenoxy)pyrido[3,4-d]pyridazin-4-ol;
7-(2,4-dichlorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-[(trans-4-hydroxycyclohexyl)amino]-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(cyclopentyloxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(2,6-dichlorobenzyl)-5-[(7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-yl)amino]pyrido[3,4-d]pyridazin-4(3H)-one;
2-(2-chlorophenoxy)-4-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
5-{[2-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]amino}-7-(4-fluoropiperidin-1-yl)pyrido[3,4-d]pyridazin-4-ol;
2-(2-chlorobenzyl)-4-[(6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]pyrido[2,3-d]pyridazin-5-ol;
2-(2-chlorobenzyl)-4-{[2-methoxy-4-(piperazin-1-ylmethyl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
5-{[2-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]amino}-7-[(cyclopropylmethyl)amino]pyrido[3,4-d]pyridazin-4-ol;
2-(2-chlorobenzyl)-4-{[2-methoxy-4-(morpholin-4-ylmethyl)phenyl]amino}pyrido[2,3-d]pyridazin-5-ol;
7-(2-chlorophenoxy)-5-{[2-ethoxy-4-(pyrrolidin-1-ylmethyl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]amino}-7-(4-hydroxypiperidin-1-yl)pyrido[3,4-d]pyridazin-4(3H)-one;
5-{[2-chloro-4-(pyrrolidin-1-ylmethyl)phenyl]amino}-7-(3-hydroxyazetidin-1-yl)pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2-chlorophenoxy)-5-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-[(cyclopropylmethyl)amino]-5-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
2-(2-chlorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2,6-dichlorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}-2-[2-(morpholin-4-yl)ethyl]pyrido[2,3-d]pyridazin-5(6H)-one;
7-(2-chlorophenoxy)-5-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
2-(2-cyclopropylethyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
(4-{[7-(2-chlorophenoxy)-4-hydroxypyrido[3,4-d]pyridazin-5-yl]amino}-3-methoxyphenyl)(pyrrolidin-1-yl)methanone;
7-(2-chlorophenoxy)-5-{[2-ethoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
2-(2-fluorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2,3-dichlorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2,6-difluorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2,5-difluorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2,3-difluorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
2-(2-chloro-6-fluorobenzyl)-4-{[2-methoxy-4-(piperidin-4-yl)phenyl]amino}pyrido[2,3-d]pyridazin-5(6H)-one;
5-[(2-methoxyphenyl)amino]-7-{[4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
7-(2-chlorophenoxy)-5-{[2-ethoxy-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4-ol;
2-[(5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-4-oxo-3,4-dihydropyrido[3,4-d]pyridazin-7-yl)oxy]benzonitrile;
2-(2-chlorobenzyl)-4-({2-methoxy-4-[(4-methylpiperazin-1-yl)methyl]phenyl}amino)pyrido[2,3-d]pyridazin-5(6H)-one;
7-(2-chlorophenoxy)-5-{[2-(difluoromethoxy)-4-(piperazin-1-yl)phenyl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2-chlorophenoxy)-5-{[5-(piperidin-4-yl)pyridin-2-yl]amino}pyrido[3,4-d]pyridazin-4(3H)-one;
7-(2-chlorophenoxy)-5-{[2-methoxy-4-(piperazin-1-yl)phenyl]amino}-1-methylpyrido[3,4-d]pyridazin-4-ol; and
2-{[7-(2-chlorophenoxy)-4-hydroxypyrido[3,4-d]pyridazin-5-yl]amino}-5-(piperazin-1-yl)benzonitrile.

### Claim 15 (depends on 1)

A pharmaceutical composition comprising a compound or pharmaceutically acceptable salt of claim 1 and pharmaceutically acceptable excipient.

### Claim 16 (depends on 1)

A method of treating cancer in a mammal comprising administering thereto a therapeutically acceptable amount of a compound or pharmaceutically acceptable salt of claim 1.

### Claim 17 (depends on 1)

A method for decreasing tumor volume in a mammal comprising administering thereto a therapeutically acceptable amount of a compound or pharmaceutically acceptable salt of claim 1.
